Advanced formulation design: Improving drug therapies for the management of severe and chronic pain

Drug Development and Industrial Pharmacy

Volumn 34, Issue 2, 2008, Pages 117-133

  Miller, Dave A ^a   DiNunzio, James C ^a   Williams III, Robert O ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Fentanyl; Gabapentin; Hydromorphone; Ketamine; Morphine; Opioid; Oxycodone; Oxymorphone; Pain management; Review

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; FENTANYL; FENTANYL CITRATE; FENTORA; GABAPENTIN; HYDROMORPHONE; IBUPROFEN; IBUPROFEN PLUS OXYCODONE; IONSYS; KETAMINE; MORPHINE; MORPHINE SULFATE; OPANA; OXYCODONE; OXYMORPHONE; PARACETAMOL; PERCOCET; PERCODAN; RAPINYL; ROXICET; ROXILOX; TAIFUN; UNCLASSIFIED DRUG;

CHRONIC PAIN; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG CAPSULE; DRUG CHOICE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DEVELOPMENT; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG SAFETY; DRUG TOLERABILITY; EXTENDED RELEASE CAPSULE; HUMAN; PAIN ASSESSMENT; REVIEW; SUSTAINED RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION; TABLET FORMULATION;

ANALGESICS; CHRONIC DISEASE; DELAYED-ACTION PREPARATIONS; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; HUMANS; NARCOTICS; PAIN;

EID: 39849098437     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701542200     Document Type: Review

References (73)